nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0175	0.0476	CcSEcCtD
Trimipramine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0455	CcSEcCtD
Trimipramine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0401	CcSEcCtD
Trimipramine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0118	0.032	CcSEcCtD
Trimipramine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0309	CcSEcCtD
Trimipramine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0297	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0284	CcSEcCtD
Trimipramine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00989	0.0269	CcSEcCtD
Trimipramine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0228	CcSEcCtD
Trimipramine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00838	0.0228	CcSEcCtD
Trimipramine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00828	0.0225	CcSEcCtD
Trimipramine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00799	0.0217	CcSEcCtD
Trimipramine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00795	0.0216	CcSEcCtD
Trimipramine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00795	0.0216	CcSEcCtD
Trimipramine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0079	0.0215	CcSEcCtD
Trimipramine—CYP2C19—urine—nephrolithiasis	0.0078	0.149	CbGeAlD
Trimipramine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00757	0.0206	CcSEcCtD
Trimipramine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00724	0.0197	CcSEcCtD
Trimipramine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00679	0.0185	CcSEcCtD
Trimipramine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00676	0.0184	CcSEcCtD
Trimipramine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0177	CcSEcCtD
Trimipramine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00643	0.0175	CcSEcCtD
Trimipramine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00621	0.0169	CcSEcCtD
Trimipramine—CYP2C9—urine—nephrolithiasis	0.00605	0.116	CbGeAlD
Trimipramine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00597	0.0162	CcSEcCtD
Trimipramine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00594	0.0161	CcSEcCtD
Trimipramine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00588	0.016	CcSEcCtD
Trimipramine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00582	0.0158	CcSEcCtD
Trimipramine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00571	0.0155	CcSEcCtD
Trimipramine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0056	0.0152	CcSEcCtD
Trimipramine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00538	0.0146	CcSEcCtD
Trimipramine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00533	0.0145	CcSEcCtD
Trimipramine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00528	0.0143	CcSEcCtD
Trimipramine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00521	0.0142	CcSEcCtD
Trimipramine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00517	0.0141	CcSEcCtD
Trimipramine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00506	0.0138	CcSEcCtD
Trimipramine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00505	0.0137	CcSEcCtD
Trimipramine—HTR2A—urine—nephrolithiasis	0.00498	0.0954	CbGeAlD
Trimipramine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00493	0.0134	CcSEcCtD
Trimipramine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00483	0.0131	CcSEcCtD
Trimipramine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00468	0.0127	CcSEcCtD
Trimipramine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00464	0.0126	CcSEcCtD
Trimipramine—CYP3A4—urine—nephrolithiasis	0.00461	0.0883	CbGeAlD
Trimipramine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0046	0.0125	CcSEcCtD
Trimipramine—Propiomazine—CHRM3—nephrolithiasis	0.00456	0.126	CrCbGaD
Trimipramine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00455	0.0124	CcSEcCtD
Trimipramine—CYP2D6—urine—nephrolithiasis	0.00454	0.0869	CbGeAlD
Trimipramine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0045	0.0122	CcSEcCtD
Trimipramine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00446	0.0121	CcSEcCtD
Trimipramine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00442	0.012	CcSEcCtD
Trimipramine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00426	0.0116	CcSEcCtD
Trimipramine—Nortriptyline—CHRM3—nephrolithiasis	0.00424	0.117	CrCbGaD
Trimipramine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00411	0.0112	CcSEcCtD
Trimipramine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00409	0.0111	CcSEcCtD
Trimipramine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00409	0.0111	CcSEcCtD
Trimipramine—Methotrimeprazine—CHRM3—nephrolithiasis	0.0039	0.108	CrCbGaD
Trimipramine—Promethazine—CHRM3—nephrolithiasis	0.00384	0.106	CrCbGaD
Trimipramine—Doxepin—CHRM3—nephrolithiasis	0.0038	0.105	CrCbGaD
Trimipramine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00371	0.0101	CcSEcCtD
Trimipramine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00366	0.00995	CcSEcCtD
Trimipramine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00962	CcSEcCtD
Trimipramine—Desipramine—CHRM3—nephrolithiasis	0.00349	0.0967	CrCbGaD
Trimipramine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00342	0.0093	CcSEcCtD
Trimipramine—Promazine—CHRM3—nephrolithiasis	0.00338	0.0937	CrCbGaD
Trimipramine—ADRA1B—renal system—nephrolithiasis	0.00336	0.0642	CbGeAlD
Trimipramine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00894	CcSEcCtD
Trimipramine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00887	CcSEcCtD
Trimipramine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00886	CcSEcCtD
Trimipramine—ADRA1B—kidney—nephrolithiasis	0.00324	0.0621	CbGeAlD
Trimipramine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00881	CcSEcCtD
Trimipramine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00307	0.00835	CcSEcCtD
Trimipramine—Chlorpromazine—CHRM3—nephrolithiasis	0.00298	0.0824	CrCbGaD
Trimipramine—Imipramine—CHRM3—nephrolithiasis	0.00296	0.082	CrCbGaD
Trimipramine—Amitriptyline—CHRM3—nephrolithiasis	0.00294	0.0815	CrCbGaD
Trimipramine—HTR1D—kidney—nephrolithiasis	0.00237	0.0454	CbGeAlD
Trimipramine—HTR1A—renal system—nephrolithiasis	0.00205	0.0392	CbGeAlD
Trimipramine—ADRA1A—renal system—nephrolithiasis	0.00189	0.0361	CbGeAlD
Trimipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00136	0.00251	CbGpPWpGaD
Trimipramine—ADRA2A—cortex of kidney—nephrolithiasis	0.00135	0.0258	CbGeAlD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00135	0.00248	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00135	0.00248	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00133	0.00244	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00128	0.00236	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00128	0.00236	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00128	0.00235	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00124	0.00227	CbGpPWpGaD
Trimipramine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00122	0.00225	CbGpPWpGaD
Trimipramine—HTR2A—renal system—nephrolithiasis	0.00122	0.0233	CbGeAlD
Trimipramine—HTR1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00122	0.00224	CbGpPWpGaD
Trimipramine—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0012	0.00221	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0012	0.00221	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0012	0.00221	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0012	0.00221	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00119	0.00219	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00119	0.00219	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00119	0.00219	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00119	0.00218	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00118	0.00217	CbGpPWpGaD
Trimipramine—HTR2A—kidney—nephrolithiasis	0.00118	0.0226	CbGeAlD
Trimipramine—ADRA2B—Hemostasis—DGKH—nephrolithiasis	0.00116	0.00214	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—SLC7A9—nephrolithiasis	0.00116	0.00214	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00114	0.00209	CbGpPWpGaD
Trimipramine—CYP3A4—renal system—nephrolithiasis	0.00113	0.0216	CbGeAlD
Trimipramine—HTR1D—GPCR ligand binding—PTH—nephrolithiasis	0.00111	0.00205	CbGpPWpGaD
Trimipramine—CYP2D6—renal system—nephrolithiasis	0.00111	0.0213	CbGeAlD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0011	0.00201	CbGpPWpGaD
Trimipramine—CYP3A4—kidney—nephrolithiasis	0.00109	0.0209	CbGeAlD
Trimipramine—ADRA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00109	0.002	CbGpPWpGaD
Trimipramine—CYP2D6—kidney—nephrolithiasis	0.00107	0.0206	CbGeAlD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00106	0.00196	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00106	0.00196	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00105	0.00193	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00105	0.00193	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00105	0.00192	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00103	0.0019	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00103	0.0019	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00103	0.0019	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00103	0.00189	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00101	0.00186	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.001	0.00184	CbGpPWpGaD
Trimipramine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.001	0.00184	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00099	0.00182	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00096	0.00177	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000955	0.00176	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000953	0.00175	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00095	0.00175	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000942	0.00173	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000938	0.00172	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000924	0.0017	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000921	0.00169	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00091	0.00167	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000909	0.00167	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000909	0.00167	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000907	0.00167	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000904	0.00166	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00089	0.00164	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ADCY10—nephrolithiasis	0.00089	0.00164	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.000884	0.00162	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.000884	0.00162	CbGpPWpGaD
Trimipramine—ABCB1—nephron tubule—nephrolithiasis	0.000879	0.0168	CbGeAlD
Trimipramine—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000866	0.00159	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000865	0.00159	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.000861	0.00158	CbGpPWpGaD
Trimipramine—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000851	0.00156	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000842	0.00155	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000842	0.00155	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000839	0.00154	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.000831	0.00153	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.000827	0.00152	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000827	0.00152	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000825	0.00152	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000823	0.00151	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000808	0.00149	CbGpPWpGaD
Trimipramine—ABCB1—renal system—nephrolithiasis	0.000799	0.0153	CbGeAlD
Trimipramine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000798	0.00147	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.000792	0.00146	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000785	0.00144	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000784	0.00144	CbGpPWpGaD
Trimipramine—ABCB1—kidney—nephrolithiasis	0.000772	0.0148	CbGeAlD
Trimipramine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000769	0.00141	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—RGS14—nephrolithiasis	0.000757	0.00139	CbGpPWpGaD
Trimipramine—ABCB1—cortex of kidney—nephrolithiasis	0.000752	0.0144	CbGeAlD
Trimipramine—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000751	0.00138	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000736	0.00135	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.00073	0.00134	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000718	0.00132	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000717	0.00132	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000714	0.00131	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000711	0.00131	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000707	0.0013	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000703	0.00129	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000689	0.00127	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000688	0.00126	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000677	0.00124	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.000668	0.00123	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000664	0.00122	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.00066	0.00121	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000653	0.0012	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000645	0.00119	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000642	0.00118	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000638	0.00117	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000638	0.00117	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000632	0.00116	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.00063	0.00116	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000625	0.00115	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000624	0.00115	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000615	0.00113	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000614	0.00113	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000613	0.00113	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000601	0.00111	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000593	0.00109	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000593	0.00109	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.000585	0.00107	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000583	0.00107	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000573	0.00105	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.000572	0.00105	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.000572	0.00105	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000567	0.00104	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000564	0.00104	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.000561	0.00103	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000561	0.00103	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000558	0.00103	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000557	0.00102	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.000556	0.00102	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000546	0.001	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000537	0.000988	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000532	0.000978	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00053	0.000975	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000529	0.000972	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000529	0.000972	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000522	0.000959	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000514	0.000944	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000511	0.00094	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.000511	0.000939	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000511	0.000939	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000507	0.000932	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000495	0.000911	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000489	0.000899	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.000488	0.000896	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000487	0.000895	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000486	0.000894	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000483	0.000888	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000477	0.000878	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000473	0.000869	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00047	0.000864	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000467	0.000859	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000467	0.000858	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000464	0.000853	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000451	0.000829	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000447	0.000823	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000444	0.000817	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000444	0.000816	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000444	0.000815	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000443	0.000814	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000442	0.000813	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000435	0.000799	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000427	0.000784	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.000424	0.00078	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000423	0.000777	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000413	0.000758	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00041	0.000753	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000406	0.000747	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000406	0.000746	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000405	0.000745	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000404	0.000742	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000403	0.000741	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000402	0.000739	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000402	0.000739	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000402	0.000739	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000397	0.000731	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000395	0.000726	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000395	0.000726	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000395	0.000725	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000381	0.000701	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000381	0.000701	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000379	0.000697	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.000379	0.000697	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000376	0.000691	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000375	0.000689	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000369	0.000679	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000369	0.000679	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.000369	0.000678	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.000368	0.000676	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000367	0.000674	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000367	0.000674	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000363	0.000667	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000363	0.000667	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000361	0.000664	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000346	0.000635	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000343	0.00063	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.000338	0.000621	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000335	0.000617	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000335	0.000616	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000335	0.000615	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000335	0.000615	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000329	0.000605	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.000329	0.000605	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000329	0.000604	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000329	0.000604	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000327	0.000601	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000322	0.000593	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000322	0.000593	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000308	0.000566	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000305	0.000561	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0003	0.000551	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.0003	0.000551	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000286	0.000527	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000285	0.000525	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000285	0.000524	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000285	0.000524	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000278	0.000511	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APRT—nephrolithiasis	0.000278	0.000511	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000276	0.000507	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000274	0.000504	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000262	0.000482	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000262	0.000482	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000262	0.000482	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.000261	0.00048	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APRT—nephrolithiasis	0.00026	0.000477	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.00026	0.000477	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000259	0.000476	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000252	0.000463	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.000251	0.000461	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000242	0.000445	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.00024	0.000441	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000238	0.000438	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000238	0.000437	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000233	0.000429	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000226	0.000415	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000221	0.000407	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.000218	0.0004	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000217	0.000399	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000217	0.000398	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000213	0.000392	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000203	0.000373	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000201	0.00037	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000198	0.000364	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000198	0.000364	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000187	0.000343	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000185	0.00034	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000184	0.000337	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000179	0.000329	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000171	0.000315	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000171	0.000315	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	0.00017	0.000312	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000169	0.00031	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000167	0.000308	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	0.000131	0.000241	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	0.000127	0.000233	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	0.000126	0.000231	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000122	0.000224	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.000121	0.000222	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000111	0.000204	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.00011	0.000203	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	0.000109	0.000201	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	0.000109	0.000201	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000107	0.000197	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	9.95e-05	0.000183	CbGpPWpGaD
